Sanofi's Deal With Medco/UBC Seeks Payer Perspective To Inform Drug R&D, Marketing
This article was originally published in The Pink Sheet Daily
Executive Summary
The multi-year, global data, research and consulting agreement will focus primarily on drugs in Phase II or III.